US 11434268
Vascular endothelial growth factor antagonists
granted A61KA61K38/1866
Quick answer
US patent 11434268 (Vascular endothelial growth factor antagonists) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/1866